FDA Inspection 844182 — Guangzhou Hanpu Pharmaceutical Co. Ltd.

Guangzhou Hanpu Pharmaceutical Co. Ltd. — FEI 3007088627

The FDA completed an inspection of Guangzhou Hanpu Pharmaceutical Co. Ltd. on Jul 19, 2013 in Guangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 19, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Guangzhou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.